PATENT CLAIM ANALYSIS

Application Number: 15866787
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "654000"]

Abstract:
Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.

Claim (Index 8):
The unit dose of  claim 1 , wherein the nasal carrier is selected from about 0.05 to about 5% w/v of a mucoadhesive agent; from about 0.2 to about 10.0% w/v of a solubilizer; from about 0.1% to about 1% of a sweetener; from about 0.01 to about 1% w/v of a preservative, from about 0.01% w/v to about 0.5% w/v of a flavouring agent and a sufficient amount of a water vehicle.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335145', '14882857', '14576357', '14950707', '12047388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588808274367689
- 35 USC 102 Novelty (BERT): 0.5237890309742672
- Combined Prediction Score: 0.7353716477905188
- Mean Citation Score: 305.51074
- Max Citation Score: 314.98096
- Similarity Product: 246.13247570710183

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test